- Super Micro Computer ( SMCI ) +20% on better-than-expected Q4 prelim results.
- ToughBuilt Industries ( TBLT ) +16% .
- MoonLake Immunotherapeutics ( MLTX ) +14% .
- Visionary Education Technology Holdings ( VEDU ) +12% .
- Olema Pharmaceuticals ( OLMA ) +11% as FDA grants fast track status to OP-1250 for breast cancer subtype.
- aTyr Pharma ( LIFE ) +11% .
- Tabula Rasa HealthCare ( TRHC ) +11% on raised Q2 revenue guidance.
- Blue Apron Holdings ( APRN ) +7% after Benchmark turns bullish.
- Nokia Oyj ( NOK ) +7% on Q2 results.
- XTL Biopharmaceuticals ( XTLB ) +7% .
- Karyopharm Therapeutics ( KPTI ) +6% wins full EU approval for multiple myeloma therapy.
For further details see:
LIFE, TBLT and XTLB among pre market gainers